Suppr超能文献

临床感染负荷对一氧化氮抗菌治疗的敏感性研究。

Investigation of the susceptibility of clinical infection loads to nitric oxide antibacterial treatment.

作者信息

Estes Bright Lori M, Mondal Arnab, Pinon Vicente, Kumar Anil, Thompson Stephen, Brisbois Elizabeth J, Handa Hitesh

机构信息

School of Chemical, Materials, and Biomedical Engineering, College of Engineering, University of Georgia, Athens, GA, 30602, USA.

Pharmaceutical and Biomedical Sciences Department, College of Pharmacy, University of Georgia, Athens, GA, 30602, USA.

出版信息

Nitric Oxide. 2025 Feb;154:19-28. doi: 10.1016/j.niox.2024.11.003. Epub 2024 Nov 17.

Abstract

The persistent infection of medical devices by opportunistic pathogens has led to the development of antimicrobial medical device polymers. Nitric oxide (NO) is an endogenous antimicrobial molecule that is released through the degradation of synthetic donor molecules such as S-nitroso-N-acetylpenicillamine (SNAP) embedded into polymer membranes. It is hypothesized that the clinical success of these polymers is enhanced by the physiological release of NO and the consequent prevention of infection. However, such NO-releasing materials have never been evaluated against microbial loads that are commensurate with clinical infection levels. This study aimed to develop a standardized polymer film impregnated with SNAP that consistently releases NO and evaluates its efficacy against bacterial loads that represent clinical infection parameters. Microbial loads of 10, 10, and 10 (colony-forming units) CFU mL were exposed to the NO-releasing polymer, corresponding to bloodstream infections, catheter-associated urinary tract infections, and standard laboratory exposure levels that have been reported in the scientific literature. By 24 h, SNAP films led to >1 log reduction of adhered and viable E. coli at all tested microbial loads compared to control polydimethylsiloxane (PDMS). Further, SNAP films displayed no viable adhered S. aureus at the 10 microbial level for the entire study and showed total planktonic killing by 8 h. NO localization within bacterial cells adhering to the films was evaluated, revealing higher NO uptake and consequent bacterial killing by SNAP samples. This unique study shows that NO-releasing polymers not only kill bacteria adhered to the polymer surface, but localized delivery leads to environmental planktonic bacterial killing that prevents adhesion from occurring. Furthermore, the promising findings of NO-releasing polymers in scientific research indicate their potential for successful application in clinical settings to prevent infections.

摘要

机会性病原体对医疗器械的持续感染促使了抗菌医疗器械聚合物的发展。一氧化氮(NO)是一种内源性抗菌分子,它通过嵌入聚合物膜中的合成供体分子(如S-亚硝基-N-乙酰青霉胺(SNAP))的降解而释放。据推测,这些聚合物的临床成功得益于NO的生理性释放以及随之而来的感染预防。然而,此类释放NO的材料从未针对与临床感染水平相当的微生物负荷进行过评估。本研究旨在开发一种浸渍有SNAP的标准化聚合物薄膜,该薄膜能持续释放NO,并评估其对代表临床感染参数的细菌负荷的疗效。将10⁵、10⁶和10⁷(菌落形成单位)CFU/mL的微生物负荷暴露于释放NO的聚合物中,分别对应血流感染、导管相关尿路感染以及科学文献中报道的标准实验室暴露水平。到24小时时,与对照聚二甲基硅氧烷(PDMS)相比,SNAP薄膜在所有测试的微生物负荷下均使粘附并存活的大肠杆菌减少了>1个对数级。此外,在整个研究过程中,SNAP薄膜在10⁷微生物水平下未检测到存活的粘附金黄色葡萄球菌,并且在8小时时显示出对浮游细菌的完全杀灭。对粘附在薄膜上的细菌细胞内的NO定位进行了评估,结果显示SNAP样品对NO的摄取更高,从而导致细菌杀灭。这项独特的研究表明,释放NO的聚合物不仅能杀死粘附在聚合物表面的细菌,而且局部递送会导致环境中浮游细菌的杀灭,从而防止粘附的发生。此外,释放NO的聚合物在科学研究中的有前景的发现表明它们在临床环境中预防感染的成功应用潜力。

相似文献

1
Investigation of the susceptibility of clinical infection loads to nitric oxide antibacterial treatment.
Nitric Oxide. 2025 Feb;154:19-28. doi: 10.1016/j.niox.2024.11.003. Epub 2024 Nov 17.
2
Anti-Infective Bacteriophage Immobilized Nitric Oxide-Releasing Surface for Prevention of Thrombosis and Device-Associated Infections.
ACS Appl Bio Mater. 2025 Feb 17;8(2):1362-1376. doi: 10.1021/acsabm.4c01638. Epub 2025 Feb 3.
3
A Synergistic New Approach Toward Enhanced Antibacterial Efficacy via Antimicrobial Peptide Immobilization on a Nitric Oxide-Releasing Surface.
ACS Appl Mater Interfaces. 2021 Sep 22;13(37):43892-43903. doi: 10.1021/acsami.1c08921. Epub 2021 Sep 13.
5
Wearable nitric oxide-releasing antibacterial insert for preventing device-associated infections.
J Control Release. 2024 Nov;375:667-680. doi: 10.1016/j.jconrel.2024.09.027. Epub 2024 Sep 24.
6
Multifunctional slippery nanoemulsion-infused porous nitric oxide-releasing surfaces.
J Colloid Interface Sci. 2025 Jul;689:137199. doi: 10.1016/j.jcis.2025.02.207. Epub 2025 Feb 28.
7
8
Combating Concomitant Bacterial and Fungal Infections via Codelivery of Nitric Oxide and Fluconazole.
ACS Appl Mater Interfaces. 2025 Apr 23;17(16):23613-23626. doi: 10.1021/acsami.5c00174. Epub 2025 Apr 14.
9
Potent, Broad-Spectrum Antimicrobial Effects of Nitroso--acetylpenicillamine-Impregnated Nitric Oxide-Releasing Latex Urinary Catheters.
ACS Appl Bio Mater. 2022 Feb 21;5(2):700-710. doi: 10.1021/acsabm.1c01130. Epub 2022 Feb 4.

引用本文的文献

1
Nitric Oxide-Releasing Polydimethylsiloxane Sponges with Tunable Porosity.
ACS Appl Mater Interfaces. 2025 Jun 18;17(24):35262-35274. doi: 10.1021/acsami.5c06963. Epub 2025 Jun 9.

本文引用的文献

1
Bioinspired superhydrophobic surfaces with silver and nitric oxide-releasing capabilities to prevent device-associated infections and thrombosis.
J Colloid Interface Sci. 2024 Jun 15;664:928-937. doi: 10.1016/j.jcis.2024.03.082. Epub 2024 Mar 15.
2
Synthesis and Characterization of Nitric Oxide-Releasing Ampicillin as a Potential Strategy for Combatting Bacterial Biofilm Formation.
ACS Appl Mater Interfaces. 2023 Mar 29;15(12):15185-15194. doi: 10.1021/acsami.3c00140. Epub 2023 Mar 16.
3
Biomimetic gasotransmitter-releasing alginate beads for biocompatible antimicrobial therapy.
J Colloid Interface Sci. 2022 Dec 15;628(Pt B):911-921. doi: 10.1016/j.jcis.2022.08.113. Epub 2022 Aug 19.
4
Dual Action Nitric Oxide and Fluoride Ion-Releasing Hydrogels for Combating Dental Caries.
ACS Appl Mater Interfaces. 2022 May 18;14(19):21916-21930. doi: 10.1021/acsami.2c02301. Epub 2022 May 4.
6
Increasing the Lifetime of Insulin Cannula with Antifouling and Nitric Oxide Releasing Properties.
ACS Appl Bio Mater. 2019 Dec 16;2(12):5965-5975. doi: 10.1021/acsabm.9b00908. Epub 2019 Nov 27.
7
Surface-Catalyzed Nitric Oxide Release via a Metal Organic Framework Enhances Antibacterial Surface Effects.
ACS Appl Mater Interfaces. 2021 Dec 8;13(48):56931-56943. doi: 10.1021/acsami.1c17248. Epub 2021 Nov 24.
8
A Synergistic New Approach Toward Enhanced Antibacterial Efficacy via Antimicrobial Peptide Immobilization on a Nitric Oxide-Releasing Surface.
ACS Appl Mater Interfaces. 2021 Sep 22;13(37):43892-43903. doi: 10.1021/acsami.1c08921. Epub 2021 Sep 13.
9
Nitric oxide releasing nanofibrous Fmoc-dipeptide hydrogels for amelioration of renal ischemia/reperfusion injury.
J Control Release. 2021 Sep 10;337:1-13. doi: 10.1016/j.jconrel.2021.07.016. Epub 2021 Jul 14.
10
Development of Novel Amphotericin B-Immobilized Nitric Oxide-Releasing Platform for the Prevention of Broad-Spectrum Infections and Thrombosis.
ACS Appl Mater Interfaces. 2021 May 5;13(17):19613-19624. doi: 10.1021/acsami.1c01330. Epub 2021 Apr 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验